Chronic β3 adrenergic agonist treatment improves brain microvascular endothelial function and cognition in aged mice

Duraipandy Natarajan,Shoba Ekambaram,Stefano Tarantini,Raghavendra Yelahanka Nagaraja,Andriy Yabluchanskiy,Andria Hendrik,Vibhudutta Awasthi,Madhan Subramanian,Anna Csiszar,Priya Balasubramanian

DOI: https://doi.org/10.1101/2024.07.09.602747

2024-07-13

Abstract:Microvascular endothelial dysfunction, characterized by impaired neurovascular coupling, reduced glucose uptake, blood-brain barrier disruption, and microvascular rarefaction, plays a critical role in the pathogenesis of age-related vascular cognitive impairment (VCI). Emerging evidence points to non-cell autonomous mechanisms mediated by adverse circulating milieu (an increased ratio of pro-geronic to anti-geronic circulating factors) in the pathogenesis of endothelial dysfunction leading to impaired cerebral blood flow and cognitive decline in the aging population. In particular, age-related adipose dysfunction contributes, at least in part, to an unfavorable systemic milieu characterized by chronic hyperglycemia, hyperinsulinemia, dyslipidemia, and altered adipokine profile, which together contribute to microvascular endothelial dysfunction. Hence, in the present study, we aimed to test whether thermogenic stimulation, an intervention known to improve adipose and systemic metabolism by increasing cellular energy expenditure, could mitigate brain endothelial dysfunction and improve cognition in the aging population. Eighteen-month-old old C57BL/6J mice were treated with saline or CL (β3-adrenergic agonist) for 6 weeks followed by functional analysis to assess endothelial function and cognition. CL treatment improved neurovascular coupling responses and rescued brain glucose uptake in aged animals. In addition, CL treatment also attenuated blood-brain barrier leakage and associated neuroinflammation in the cortex of aged animals. More importantly, these beneficial changes in microvascular function translated to improved cognitive performance in radial arm water maze and Y-maze tests. Our results suggest that β3-adrenergic agonist treatment improves multiple aspects of brain microvascular endothelial function and can be potentially repurposed for treating age-associated cognitive decline.

Neuroscience

What problem does this paper attempt to address?

The paper attempts to address the issue of aging-related microvascular endothelial dysfunction and cognitive decline. Specifically, the researchers aim to improve the metabolic function of mice using a β3-adrenergic agonist and investigate whether this intervention can alleviate age-related brain microvascular endothelial dysfunction and cognitive decline.

### Main Research Content
- **Background**: With aging, microvascular endothelial dysfunction leads to impaired neurovascular coupling, reduced glucose uptake, blood-brain barrier disruption, and microvascular rarefaction. These factors collectively result in decreased cerebral blood flow and cognitive decline.
- **Mechanism**: Studies have shown that an adverse circulatory environment (imbalance between pro-aging and anti-aging factors) plays a crucial role in endothelial dysfunction. Particularly, age-related adipose tissue dysfunction leads to chronic hyperglycemia, hyperinsulinemia, dyslipidemia, and altered adiponectin profiles, which collectively promote microvascular endothelial dysfunction.
- **Intervention**: The researchers used a β3-adrenergic agonist (CL 316,243), a drug known to enhance adipose tissue and systemic metabolic levels, to test whether it can alleviate brain endothelial dysfunction and improve cognitive function in aging mice.

### Overview of Results
- **Experimental Design**: 18-month-old C57BL/6J mice were treated with a β3-adrenergic agonist for 6 weeks.
- **Main Findings**:
- CL treatment significantly improved neurovascular coupling response and brain glucose uptake in aged mice.
- Reduced blood-brain barrier leakage and associated neuroinflammation.
- Improved spatial learning and memory performance in aged mice in the radial arm water maze and Y-maze tests.
- **Mechanism Exploration**: The researchers believe that CL treatment may act through multiple pathways, including increasing GLUT1 expression on endothelial cells to enhance brain glucose uptake, thereby restoring blood-brain barrier integrity and reducing neuroinflammation.

### Summary
This study reveals the potential of β3-adrenergic agonists in improving age-related brain microvascular endothelial dysfunction and cognitive decline, providing new insights for the development of treatments for cognitive impairment in the elderly.